Activation_NN
of_IN
Ras_NN
and_CC
mitogen-activated_JJ
protein_NN
kinase_NN
pathway_NN
by_IN
terminal_JJ
complement_NN
complexes_NNS
is_VBZ
G_NN
protein_NN
dependent_JJ
._.

Assembly_NN
of_IN
terminal_JJ
complement_NN
complexes_NNS
-LRB-_-LRB-
TCC_NN
-RRB-_-RRB-
C5b-7_NN
,_,
C5b-8_NN
,_,
and_CC
C5b-9_NN
on_IN
target_NN
cells_NNS
during_IN
acute_JJ
and_CC
chronic_JJ
inflammation_NN
induces_VBZ
hydrolysis_NN
of_IN
plasma_NN
membrane_NN
phospholipids_NNS
and_CC
heterotrimeric_JJ
G_NN
protein_NN
activation_NN
._.

TCC_NN
also_RB
stimulate_VBP
a_DT
variety_NN
of_IN
cellular_JJ
activities_NNS
,_,
which_WDT
include_VBP
cytokine_NN
synthesis_NN
,_,
proto-oncogene_NN
activation_NN
,_,
and_CC
mitotic_JJ
signaling_NN
._.

Now_RB
we_PRP
report_VBP
that_IN
sublytic_JJ
TCC_NN
induced_VBD
Ras_NN
,_,
Raf-1_NN
,_,
and_CC
extracellular_JJ
signal-regulated_JJ
kinase_NN
-LRB-_-LRB-
ERK_NN
-RRB-_-RRB-
1_CD
activation_NN
in_IN
JY25_NN
B_NN
cell_NN
line_NN
._.

When_WRB
cells_NNS
were_VBD
exposed_VBN
to_TO
C5b-9_NN
,_,
GTP-bound_JJ
Ras_NN
in_IN
anti-C5b-9_JJ
immunoprecipitates_NNS
was_VBD
increased_VBN
3.2-fold_RB
at_IN
2_CD
min_NN
,_,
while_IN
GTP-bound_JJ
Ras_NN
in_IN
anti-Ras_JJ
immunoprecipitates_NNS
was_VBD
increased_VBN
2-fold_RB
at_IN
10_CD
min_NN
._.

Both_CC
C5b-9_NN
and_CC
C5b-7_NN
,_,
but_CC
not_RB
C5b6_NN
,_,
increased_VBD
Raf-1_NN
kinase_NN
activity_NN
maximum_NN
3.3-fold_RB
at_IN
2_CD
min_NN
and_CC
2.8-fold_RB
at_IN
5_CD
min_NN
,_,
respectively_RB
._.

ERK1_NN
activity_NN
was_VBD
2-fold_RB
increased_VBN
by_IN
C5b-9_NN
at_IN
2_CD
min_NN
and_CC
by_IN
C5b-7_CD
at_IN
10_CD
min_NN
,_,
over_IN
the_DT
C5b6_NN
level_NN
._.

The_DT
role_NN
of_IN
mitogen-activated_JJ
protein_NN
kinase_NN
-LRB-_-LRB-
MAPK_NN
-RRB-_-RRB-
pathway_NN
on_IN
TCC-inducible_JJ
mitotic_JJ
signaling_NN
was_VBD
evaluated_VBN
by_IN
assessing_VBG
DNA_NN
synthesis_NN
and_CC
activator_NN
protein_NN
1_CD
-LRB-_-LRB-
AP-1_NN
-RRB-_-RRB-
DNA-binding_JJ
activity_NN
._.

The_DT
MAPK\/ERK-specific_JJ
inhibitor_NN
PD_NN
098,059_CD
abolished_VBD
the_DT
C5b-9-induced_JJ
DNA_NN
synthesis_NN
._.

Involvement_NN
of_IN
G_NN
protein_NN
in_IN
the_DT
activation_NN
of_IN
MAPK_NN
pathway_NN
by_IN
TCC_NN
was_VBD
indicated_VBN
by_IN
inhibition_NN
of_IN
Raf-1_NN
and_CC
ERK1_NN
kinase_NN
activity_NN
,_,
as_RB
well_RB
as_IN
the_DT
DNA_NN
synthesis_NN
by_IN
pretreatment_NN
of_IN
cells_NNS
with_IN
pertussis_NN
toxin_NN
._.

Overexpression_NN
of_IN
beta-adrenergic_JJ
receptor_NN
kinase_NN
1_CD
carboxyl-terminal_JJ
peptide_NN
in_IN
JY25_NN
cells_NNS
also_RB
inhibited_VBD
Raf-1_NN
and_CC
ERK1_NN
activity_NN
,_,
indicating_VBG
a_DT
direct_JJ
involvement_NN
of_IN
G_NN
betagamma_NN
subunits_NNS
in_IN
the_DT
signal_NN
transduction_NN
generated_VBN
through_IN
activation_NN
of_IN
MAPK_NN
pathway_NN
by_IN
TCC_NN
assembly_NN
in_IN
the_DT
plasma_NN
membrane_NN
._.

